Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
XPF Monoclonal Antibody (51), Invitrogen™
Mouse Monoclonal Antibody
Supplier: Thermo Scientific MA512060

Description
MA5-12060 targets XPF in WB applications and shows reactivity with Human samples. The MA5-12060 immunogen is recombinant human XPF protein.
The structure specific ERCC 1 / XPF endonuclease complex is implicated in the repair of two distinct types of lesions in DNA: NER for UV induced lesions and bulky chemical adducts; and recombination repair of the very genotoxic interstrand cross links. NER mechanism involves dual incisions on both sides of the damage catalyzed by two nucleases. In mammalian cells, XPG cleaves 3' of the DNA lesion while the ERCC1 / XPF complex makes the 5' incision. ERCC1 / XPF probably plays a role in processing partially processed recombination intermediates.
Specifications
XPF | |
Monoclonal | |
0.2 mg/mL | |
PBS with 0.2% BSA and 0.09% sodium azide, pH 7.4 | |
Q92889 | |
ERCC4 | |
Recombinant human XPF protein | |
500 μL | |
Primary | |
Human | |
Liquid |
ChIP Assay, Western Blot | |
51 | |
Unconjugated | |
ERCC4 | |
AI606920, DNA excision repair protein ERCC-4, DNA repair endonuclease subunit, DNA repair endonuclease XPF, DNA repair protein complementing XP-F cells, ERCC excision repair 4, endonuclease catalytic subunit, ERCC11, ERCC4, Ercc4 protein-like, excision repair cross-complementation group 4, excision repair cross-complementing rodent repair deficiency, complementation group 4, excision-repair, complementing defective, in Chinese hamster, FANCQ, RAD1, RGD1560340, Xeroderma pigmentosum group F-complementing protein, xeroderma pigmentosum, complementation group F, XFEPS, XPF | |
Mouse | |
Protein A | |
RUO | |
2072 | |
4°, C | |
IgG2b κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction